USA |OTCQB |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||14.51%||Ex-Dividend Date|
|Held by Institutions||5.69%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Jun 21||Mar 21||Dec 20|
Aequus pharmaceuticals inc trades on the OTC Markets stock market in USA under the ticker symbol "AQSZF". Aequus pharmaceuticals inc’s stock symbol can also be displayed as "OTCMKTS:AQSZF".
Aequus pharmaceuticals inc (OTCMKTS:AQSZF) is owned by 5.69% institutional shareholders and by 14.51% insiders. The rest is owned by the public.
Explore More Details on Aequus pharmaceuticals inc's “Ownership” Section
Aequus pharmaceuticals inc's key executive team includes the following managers:
Aequus pharmaceuticals inc (OTCMKTS:AQSZF) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.
Currently the number of employees working for Aequus pharmaceuticals inc is 0.
Aequus pharmaceuticals inc (OTCMKTS:AQSZF) is headquartered in BC, Canada.
Aequus pharmaceuticals inc’s mailing address is 200 Granville Street, Vancouver, BC, Canada, V6C 1S4.
The company’s phone number is 604 336 7906.